Status:

COMPLETED

Effect of VPro5 Therapy on Clear Aligner Therapy

Lead Sponsor:

Mani Alikhani

Collaborating Sponsors:

Propel Orthodontics, LLC

Conditions:

Malocclusion

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

The investigators hypothesize that brief, daily application of HFA will increase the efficiency of clear aligner treatment by altering PDL metabolism without increasing pain or discomfort. The investi...

Eligibility Criteria

Inclusion

  • Subject must be 18 - 45 years of age
  • Subject is willing and able to comply with all study procedures and sign Informed consent/HIPAA forms
  • Subject must have complete adult dentition (excluding third molars)
  • Subjects must have class I malocclusion or mild class II/III malocclusions
  • Subject is at least one month into aligner treatment.
  • Subject has history of and current healthy oral hygiene (PD is\<4mm, GI\<1, and PI=1)

Exclusion

  • Subjects who have received periodontal treatment in the previous 6 months
  • Subjects who are taking medication that could affect the level of inflammation, such as chronic antibiotics, phenytoin, cyclosporin, ant-inflammatory drugs, systemic corticosteroids, or calcium channel blockers.
  • Subjects missing adult teeth (except the 3rd molars) or with severe class II or class III malocclusion.
  • Subjects with skeletal class I but extreme dental malocclusion
  • Severe crowding that require extraction
  • More than 4 mm positive overjet and more than 2 mm negative overjet
  • Extreme deep bite (more than 90%);
  • Severe openbite (more than 2 mm)
  • Pregnant women
  • Subjects do not have any systemic diseases effecting bone metabolism
  • Smoking
  • Vulnerable subjects per IRB definitions
  • Subjects with current caries
  • Subjects that require interproximal reduction or attachments during the study period
  • Subjects who are non-compliant regarding aligner wear or VPro5 recommended daily usage

Key Trial Info

Start Date :

February 3 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 20 2017

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03240770

Start Date

February 3 2017

End Date

July 20 2017

Last Update

August 7 2017

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

CTOR

Hoboken, New Jersey, United States, 07030

2

Orthodontia Studio

Hoboken, New Jersey, United States, 07030

3

House of Orthodontia

Brooklyn, New York, United States, 11201

4

Atique Orthodontics

San Antonio, Texas, United States, 78259